Mutations Position Table
PSEN1 I168 Mutations
| Mutation | Clinical Phenotype |
Pathogenicity | Neuropathology | Biological Effect | Genomic Position | Genomic Region | Mutation Type Codon Change |
Research Models |
Primary Papers |
|---|---|---|---|---|---|---|---|---|---|
| I168del (TATdel) (-, I167del) |
Alzheimer's Disease | Alzheimer's Disease : Pathogenic | Unknown |
Decreased Aβ42 production and undetectable production of Aβ40 in vitro. Predicted pathogenic in silico. |
rs63750879 |
Coding Exon 6 |
Deletion ATT.ATA to ATA |
0 | Janssen et al., 2003 |
| I168del (TTAdel) (-, I167del) |
Alzheimer's Disease | Alzheimer's Disease : Pathogenic | Unknown. |
Decreased Aβ42 production and undetectable production of Aβ40 in vitro. Predicted pathogenic in silico. |
Coding Exon 6 |
Deletion TTA to --- |
0 | Jiao et al., 2014 | |
| I168dup |
Alzheimer's Disease, Myoclonus | Alzheimer's Disease : Pathogenic | Neuropatholgoy consistent with AD in one case. |
Unknown, but in silico algorithms (PROVEAN and SIFT) predicted pathogenicity and CADD score was 20.2. |
Coding Exon 6 |
Duplicaton --- to ATA |
0 | O'Connor et al., 2021 | |
| I168T |
Alzheimer's Disease | Alzheimer's Disease : Pathogenic | Neuropathology consistent with AD. |
Decreased Aβ42 production and abrogated Aβ40 production in vitro; predicted possibly damaging in silico. |
Coding Exon 6 |
Point, Missense ATA to ACA |
0 | Sassi et al., 2014 |
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.